Evidence map›Paper›PMID 42432692›Full record

ArticleCancer cell international2026

Imaging mass cytometry reveals novel cellular neighborhoods for predicting the prognosis of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.

Bowen Xu, Xianming Wang, Xin Geng, Xiaofei Ye, Wendi Bi, Qinyi Jia, Xiaojuan Sun, Ji Hu, Shuzhen Chen, Guangyong Zhang and 2 more

Abstract read
In one paragraph

Article in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bowen Xu *The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Xianming Wang *Department of General Surgery, The First Affiliated Hospital of Shandong, First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, Shandong, China.
Xin GengThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Xiaofei YeDepartment of Military Health Service, Naval Medical University, Shanghai, 200433, China.
Wendi BiThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Qinyi JiaThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Xiaojuan SunThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Ji HuThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Shuzhen ChenThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China.
Guangyong ZhangDepartment of General Surgery, The First Affiliated Hospital of Shandong, First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, Shandong, China. guangyongzhang@hotmail.com.
Yang GeSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. geyang19861026@icloud.com.
Wen WenThe Third Affiliated Hospital of Naval Medical University (Second Military Medical University), National Center for Liver Cancer, 225 Changhai Road, Shanghai, 200438, China. wenwen_smmu@163.com.

Funding

Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0523300Shanghai Key Discipline of Public Health Grants Award GWVI-11.1-20the National Natural Science Foundation of China 82203323the National Natural Science Foundation of China 82472914the National Natural Science Foundation of China 82574152the Sanming Project of Medicine in Shenzhen SZSM202311019
6 · The paper itself

Abstract

objectiveWe aimed to examine the panoramic cellular composition and spatial structure of clinical samples from nonalcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC), assess the landscape of the tumor microenvironment (TME) and identify potential clinical biomarkers for prognosis.

methodsImaging mass cytometry (IMC) technology was used to analyze biomarker expression and spatial distribution in samples from 56 patients with NAFLD-HCC. Thirty-seven distinct metal-conjugated antibodies were designed to label the tumor, border and adjacent tissue regions, producing 367 highly multiplexed histological images at single-cell resolution. By combining biomarker expression levels with relative cell positional relationships, we defined functional units as tightly interacting cellular neighborhoods (CNs). Univariate and multivariate Cox regression models were employed to identify independent risk factors for prognosis assessment in patients with NAFLD-HCC on the basis of the proportion of CNs and other conventional clinical indicators.

resultsEighteen clusters of cells and 9 CNs were defined. Heterogeneity in the TME and CN composition was observed not only across various regions within the same individual but also among comparable regions in different patients. Overall survival data revealed that patients with high enrichment of GPC3

conclusionOur study provides a landscape of NAFLD-HCC and its TME characteristics from a topological perspective. These findings indicate that targeting GPC3

Indexed as

Cellular neighborhoodsImaging mass cytometryNAFLD-HCCTumor microenvironmentYAP+ cancer cells

Identifiers

PMID42432692
PMCPMC13637244

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.